Latest Operational Costs News

Vitasora Health Limited reported robust patient program growth and secured new US partnerships, driving revenue above A$1 million for the quarter. A recent A$11 million capital raise positions the company for continued expansion and cash-flow breakeven by late 2026.

Imugene Limited reports an 81% overall response rate in its azer-cel CAR T-cell therapy trial for difficult lymphomas, alongside a $25 million capital raise that extends its cash runway to mid-2027.

Stakk Limited reports a staggering 1,836% year-on-year increase in quarterly receipts, positioning itself on track to hit an $8 million annual recurring revenue target by mid-2026.

Uscom Limited reported a 27% drop in cash reserves for Q1 2025, driven by declining revenue and rising costs, while preparing to sell its main business unit to stabilize finances.

Hawsons Iron Limited reports solid progress on its Preliminary Feasibility Study for the Hawsons Iron Project, alongside promising metallurgical research with CSIRO and a successful $1.9 million capital raise.

Surefire Resources reports robust drilling results at its Yidby Gold Project alongside promising assays from its Victory Bore critical minerals deposit, supported by a $1.54 million capital raise.

Argent Minerals reports exceptional silver grades from deep drilling at Kempfield, alongside bonanza gold results at Trunkey Creek and new copper-gold targets at West Wyalong, supported by a $4.85 million capital raise.

Memphasys has sharpened its commercial focus on the Felix™ System, securing a major distribution expansion in the MENA region and cutting operational costs by 40%, setting the stage for a global market push.

Aeris Resources has announced a significant $90 million equity raise through a placement and share purchase plan, aiming to strengthen its balance sheet and fund key growth projects. The raise comes with a discount to recent share prices and supports the company’s strategic expansion and operational improvements.

Opthea has significantly reduced its operating costs and settled a key financial liability, positioning itself for a strategic review aimed at unlocking shareholder value.

PhosCo Ltd reports breakthrough drilling results at its Gasaat Phosphate Project in Tunisia, securing a €1M grant from EBRD and a $1.1M investment from its Managing Director, setting the stage for a pivotal feasibility study.

Elevate Uranium has raised $25 million through a well-supported placement, boosting its cash reserves to nearly $44 million. The funds will accelerate its proprietary U-pgrade™ pilot plant and expand uranium resource drilling in Namibia and Australia.